1. Introduction {#sec1}
===============

Elevated total cholesterol (TC), elevated low-density lipoprotein cholesterol (LDL-C), elevated non-high-density lipoprotein cholesterol (non-HDL-C), high triglycerides (TG) and low high-density lipoprotein cholesterol (HDL-C) are all suggesting of dyslipidemia that are lipid metabolism disorder \[[@bib1],[@bib2]\]. Lipid serum levels abnormalities, including overproduction or deficiency, have been recognized as an independent risk factor in the progression of cardiovascular disease (CVD) \[[@bib3]\]. Nearly all of the clinical impacts of cardiovascular disease take place in middle aged persons. Yet, studies in the previous four decades have more and more indicated that the development of atherosclerotic lesions begins in childhood and progresses all over the lifetime \[[@bib1],[@bib3],[@bib4]\].

High plasma concentrations of lipids, particularly cholesterol, are associated with a causal relationship to the pathogenesis of atherosclerosis, the process responsible for most cardiovascular diseases that include coronary, peripheral cerebrovascular and vascular diseases. Cardiovascular diseases are the leading cause of death in France and the United Kingdom: about one quarter of deaths (more in women than in men) are attributable to coronary heart disease \[[@bib5]\]. Most affected subjects are under 60 years of age. Effective management of hypercholesterolemia and other risk factors has demonstrated all its benefits in reducing cardiovascular mortality \[[@bib2],[@bib6],[@bib7]\].

According to the World Health Organization (WHO), the leading cause of death worldwide is ischemic heart disease followed by stroke. They announced that in 2015, 8.75 million deaths were due to heart disease and 6.24 million deaths were due to stroke. That\'s why dyslipidemia in children is a very important subject to deal with.

1.1. Epidemiology {#sec1.1}
-----------------

There are no available data on the prevalence of dyslipidemic children in Lebanon \[[@bib8]\].The predictable prevalence of familial hypercholesterolemia (FH) differs significantly among studies \[[@bib9]\].We estimated around 20% of worldwide children who have lipid disorders and the majority of them are not diagnosed \[[@bib10]\].

According to the National Health and Nutrition Examination Surveys (NHANES) study who included 36 949 subjects, the estimated prevalence of FH in US adults was 0.40%, or a prevalence of 1 in 250 while the reported prevalence was 1 in 500 persons \[[@bib9],[@bib11]\]. The NHANES study also reported that 50% of those with familial hypercholesterolemia had a personal or family history of early cardio vascular event and 80% of them were under pharmacological management \[[@bib11],[@bib12]\].

1.2. Atherosclerosis in the pediatric population {#sec1.2}
------------------------------------------------

Lipid disorders usually start in infancy and teenage years and remain until adult life \[[@bib1]\]. While the clinical symptoms of atherosclerosis manifest in adulthood, some studies such as the Bogalusa Heart study and the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study, showed that fatty streaks are present in the aorta from the first decade and in the coronary arteries by the second decade \[[@bib13]\]. So hyperlipidemia in children is associated to early atherosclerosis, and eventually to early CVD \[[@bib1],[@bib13]\].

Some studies demonstrate that the process of atherosclerosis initiate in early life like the autopsy studies proving the presence of atherosclerotic lesions in the pediatric population and some other indirect studies \[[@bib4],[@bib13]\]. The relationship among adult cardiovascular risk factors and early atherosclerosis was also revealed by these studies \[[@bib13]\].

### 1.2.1. The Bogalusa Heart study {#sec1.2.1}

The investigators made autopsies on 204 young people aged between 2 and 39 years old who have died from non-cardiac causes, especially traumatic etiologies, to evaluate the presence of atherosclerotic lesion in asymptomatic young people \[[@bib4],[@bib13], [@bib14], [@bib15]\]. They confirmed the presence of fatty streaks in 50% of people aged between two and fifteen years old and in 85% of cases aged 21--39 years old \[[@bib15]\]. So the degree of arterial wall surface covered with fatty streak increased with age \[[@bib4],[@bib14]\].

### 1.2.2. The PDAY study {#sec1.2.2}

The investigators made autopsies on 2876 people, aged between 15 and 34 years old, who died mainly from trauma or suicide. ^4,13,16,17^They studied the association between CVD risk factors measured at the time of autopsy and the degree of fatty streaks and fibrous plaques in the aortic artery and the right coronary artery in adolescents and young adults, and establish an association between the severity of atherosclerotic lesions and the elevated number of conventional risk factors \[[@bib16],[@bib17]\].

### 1.2.3. The muscatine study {#sec1.2.3}

It is a noninvasive, indirect study made on 725 adults aged between 33 and 42 years old who correspond to a group followed from the time when they were children \[[@bib18]\]. The investigators evaluated Carotid Intimal Medial Thickness (CIMT) using ultrasonography. The carotid intimal medial thickness has been validated as a marker of the atherosclerotic progression in adult \[[@bib4],[@bib18]\].

1.3. Lipid profile indications in children {#sec1.3}
------------------------------------------

It is documented that we could neglect up to 36% of children who are dyslipidemic if we only screen subject with a positive family history, so we needed a precise guideline on how to screen these children \[[@bib1],[@bib3]\]. The United State National Heart Lung and Blood institute (NHLBI) set up guidelines that suggested screening for kids for lipid disorders according to their ages \[[@bib1]\]. In this study, we will focus on specific ages for the screening.

-Between 2 and 8 years old: we should only do a selective screening for children with risk factors for early cardiovascular disease. A fasting lipid profile (FLP) is the ideal primary screening test.

According to the data from NHANES the difference between nonfasting and fasting lipid measurements is minimal so the screening test could be done with a non FLP but the decision upon starting treatment with a lowering agent must be based on a FLP \[[@bib11]\].

2. The study {#sec2}
============

There is a significant correlation between CVD predisposing factors and high level of TC, LDL, TG and low level of HDL-C. While the prevalence of dyslipidemia in adults has been reported to be 10 times higher in Lebanon compared to Western countries, data on the prevalence of dyslipidemic children in Lebanon is lacking \[[@bib3],[@bib8]\]. After reviewing previous research, the United State National Heart Lung, and Blood institute (NHLBI) expert panel established guidelines that recommend selective screening for children between two and ten years old for lipid disorders in only those with a positive history of some risk factors \[[@bib19]\].

2.1. Objectives {#sec2.1}
---------------

This study was conducted to assess the benefit of a protocol for universal screening for lipid disorders in Lebanese children aged between two and ten years old.

2.2. Methods and materials {#sec2.2}
--------------------------

This study is a descriptive study including several variable such as age, sex, BMI≥95th percentile, passive smoking, child with known dyslipidemia, parents with TC \> 240 mg/dL, first or/and second degree parents with premature coronary artery disease or equivalent, parents with diabetes mellitus, parents with hypertension.

The study was conducted from August 2015 to December 2017 after approval from the hospital\'s ethics committee.

2.3. Data acquisition {#sec2.3}
---------------------

A total of four hundred children aged 2--10 years old were included in the study. These subjects were recruited from private pediatric clinics after parental consent during regular visit. Pediatricians were asked to fill a questionnaire for consenting parents. Weight and height were measured and BMI was calculated using the calculator provided by the Centers for Disease Control and Prevention (CDC) that provided the BMI-for age percentile on a CDC BMI-for-age growth chart. A 12 h fasting total cholesterol, triglycerides, LDL, HDL levels were measured using enzymatic photometric test or enzymatic color test and non-HDL cholesterol was calculated. The values were categorized according to "2011 Expert on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents" \[[@bib1]\]; the levels of lipid were categorized into three groups, the high risk group was defined having a TC ≥ 200 mg/dL, TG ≥ 100 mg/dL for 2--9 years old and ≥130 mg/dL for the age of 10, LDL ≥130 mg/dL, non HDL-C ≥145 mg/dL, HDL \<40 mg/dL, the borderline group was defined having TC between 170 and 199 mg/dL, TG 75--99 mg/dL for 2--9 years old and 90--129 mg/dL for the age of 10, LDL 110--129 mg/dL, non HDL-C 120--144 mg/dL, HDL 40--45 mg/dL, and the acceptable group was defined having TC \< 170 mg/dL, TG \< 75 mg/dL for 2--9 years old and \<90 mg/dL for the age of 10, LDL \<110 mg/dL, non HDL-C \<120 mg/dL and HDL \>45 mg/dL.

2.4. Statistical analysis {#sec2.4}
-------------------------

With a 95% confidence interval and a margin of error of 5%, the data were analyzed using Statistical Package for Social Science (SPSS) software version 22. The qualitative variables are expressed as a percentage and the quantitative variables values are expressed as an average ± Standard deviation. A value of *P* \< 0.05 is considered significant. The descriptive statistics as well as the bivariate analysis of the study were calculated using the Student\'s test and the chi-square tests: Pearson Chi Square for parametric tests and Fisher Exact Test for nonparametric tests and for the analysis of risk factors for dyslipidemia in children.

3. Results {#sec3}
==========

3.1. Descriptive study {#sec3.1}
----------------------

The study recruited 400 children including 206 males (51.5%) and 194 females (48.5%). From this sample, 78 child were exposed to second hand smoking (19.5%), 45 had a BMI≥ 95th Percentile (11.3%), 21 with known dyslipidemia (5.3%), 77 having parents with TC \> 240 mg/dL (19.3%),9 having a first degree parents with premature coronary artery disease or equivalent (2.3%), 21 having a second degree parents with premature coronary artery disease or equivalent (5.3%),29 having a first or/and second degree parents with premature coronary artery disease or equivalent (7.2%), 24 having parents with diabetes mellitus (6%), 15 having parents with hypertension (3.8%) and 201 Children with criteria that qualify them for screening (50.2%).

The overall prevalence of high TC, high non-HDL-C, high LDL, high TG and low HDL was respectively 19.5%, 23%, 19%, 31.8% and 20%. The overall prevalence of borderline-high TC, non-HDL-C, LDL, TG and low HDL was respectively 47%, 44.8%, 36%, 53.3% and 37%.

3.2. Distribution of dyslipidemia according to age groups {#sec3.2}
---------------------------------------------------------

In the borderline high risk group, the overall frequency of dyslipidemia was 77.3% and the highest frequency of dyslipidemia was found at 10 years old (17.8%) while in the high risk group overall frequency of dyslipidemia was 51.7% and the highest frequency of dyslipidemia was found at the age of 6 (15.9%) ([Fig. 1](#fig1){ref-type="fig"}, [Fig. 2](#fig2){ref-type="fig"}).Fig. 1Percentage of dyslipidemic and non-dyslipidemic children by age groups in the borderline high risk group.Fig. 1Fig. 2Percentage of dyslipidemic and non-dyslipidemic children by age groups in the high risk group.Fig. 2

3.3. The bivariate analysis in the borderline high risk group {#sec3.3}
-------------------------------------------------------------

In a bivariate analysis of the borderline high risk group, dyslipidemia in children was associated with a BMI ≥95th percentile, with female gender and with parents having TC \> 240 mg/dL with a *P* value respectively of .006, .029 and .0001 ([Table 1](#tbl1){ref-type="table"}).Table 1Bivariate analysis of the variables included in the study (according to the borderline high risk group.Table 1Independents variablesDyslipidemia\
*Percentage (numbers)*No dyslipidemia\
*Percentage (numbers)P* valueGenreMale48.5 (150)61.5 (56).029\*Female51.5 (159)38.5 (35)Passive smokingYes20.4 (63)16.5 (15).409No79.6 (246)83.5 (76)BMI≥ 95th percentileYes13.6 (42)3.3 (3).006\*No86.4 (267)96.7 (88)Parents having TC \> 240 mg/dLYes22.7 (70)7.7 (7).001\*No77.3 (239)92.3 (84)First degree parents with premature coronary artery disease or equivalentYes2.3 (7)2.2 (2).97No97.7 (302)97.8 (89)Second degree parents with premature coronary artery disease or equivalentYes6.1 (19)2.2 (2).137No93.9 (290)97.8 (89)First or/and second degree parents with premature coronary artery disease or equivalentYes8.1 (25)4.4 (4).232No91.9 (284)95.6 (87)Parents with diabetesYes5.8 (18)6.6 (6).786No94.2 (291)93.4 (85)Parents with hypertensionYes3.6 (11)4.4 (4).712No96.4 (298)95.6 (87)[^1][^2]

Furthermore, according to the Pediatric Dyslipidemia Screening Guidelines from the 2011 Expert Panel, in the borderline high risk group 57.6% of dyslipidemic children had at least 1 risk factor that qualified them for screening while 42.4% of them didn\'t have any risk factor and was significant with a *P* value of .0001. Children qualified for screening has higher frequency of dyslipidemia compared to those not qualified for screening and this is a big percentage of missed children ([Table 2](#tbl2){ref-type="table"}).Table 2Bivariate analysis of children qualified for screening in the borderline high risk group.Table 2Independents variablesDyslipidemia\
*Percentage (numbers)*No dyslipidemia\
*Percentage (numbers)P* valuechildren qualified for screeningYes57.6 (178)25.3 (23).0001\*No42.4 (131)74.7 (68)[^3]

Additionally, in the borderline high risk group, high TG was independently associated with a BMI ≥ 95th percentile (*P* = .0001) ([Table 3](#tbl3){ref-type="table"}).Children with parents having TC \> 240 mg/dL was significantly correlated with high TC, high non-HDL-C and high LDL (*P* = 0.0001 for all variables) ([Table 4](#tbl4){ref-type="table"}). There was a significant gender difference and females had a more significantly elevated TC (*P* = 0.049) and elevated non-HDL-C (*P* = 0.040). ([Table 5](#tbl5){ref-type="table"}).Table 3Bivariate analysis of BMI in the borderline high risk group.Table 3Independents variablesBMI ≥95th percentile\
*Percentage (numbers)*BMI \< 95th percentile\
*Percentage (numbers)P* valueTotal cholesterol *(mg/dL)*\<17048.9 (22)53.5 (190).558≥17051.1 (23)46.5 (165)HDL *(mg/dL)*\<4026.7 (12)19.2 (68).235≥4073.3 (33)80.8 (287)Non-HDL-C *(mg/dL)*\<12044.4 (20)56.6 (201).122≥12055.6 (25)43.4 (154)LDL *(mg/dL)*\<11071.1 (32)63.1 (224).291≥11028.9 (13)36.9 (131)TG *(mg/dL)*\<7515.6 (7)50.7 (180.0001\*≥7584.4 (38)49.3 (175)[^4]Table 4Bivariate analysis of parents high TC in the borderline high risk group.Table 4Independents variablesParents with TC \> 240\
*Percentage (numbers)*Parents with TC ≤ 240\
*Percentage (numbers)P* ValueTotal Cholesterol *(mg/dL)*\<17031.5 (25)57.9 (187).0001\*≥17067.5 (52)41.1 (136)HDL *(mg/dL)*\<4024.7 (19)18.9 (61).254≥4075.3 (58)81.1 (262)Non-HDL-C *(mg/dL)*\<12031.2 (24)61 (197).0001\*≥12068.8 (53)39 (126)LDL *(mg/dL)*\<11041.6 (32)69.3 (224).0001\*≥11058.4 (45)30.7 (99)TG *(mg/dL)*\<7539 (30)48.6 (157).127≥7561 (47)51.4 (166)[^5]Table 5Bivariate analysis of gender in the borderline high risk group.Table 5Variables independentsMale\
*Percentage (numbers)*Female\
*Percentage (numbers)P* valueTotal Cholesterol *(mg/dL)*\<17057.8 (119)47.9 (93).049\*≥17042.2 (87)52.1 (101)HDL *(mg/dL)*\<4018 (37)22.2 (43).294≥4082 (169)77.8 (151)Non-HDL-C *(mg/dL)*\<12060.2 (124)97 (50).040\*≥12039.8 (82)97 (50)LDL *(mg/dL)*\<11067 (138)60.8 (118).199≥11068 (33)39.2 (76)TG *(mg/dL)*\<7549.5 (102)43.8 (85).253≥7550.5 (104)56.2 (109)[^6]

In the borderline high risk group, children not qualified for screening had a significant correlation with an elevated TC, high non-HDL-C, high TG with a P value of .0001 and with high LDL with a *P* value of .002 ([Table 6](#tbl6){ref-type="table"}).Table 6Bivariate analysis of children qualified for screening in the borderline high risk group.Table 6Independents variablesQualified for screening\
*Percentage (numbers)*Not qualified for screening\
*Percentage (numbers)P* valueTotal cholesterol *(mg/dL)*\<17040.8 (82)65.3 (130).0001\*≥17059.2 (119)34.7 (69)HDL *(mg/dL)*\<4023.9 (48)16.1 (32).051≥4076.1 (153)83.9 (167)Non HDL *(mg/dL)*\<12044.3 (89)66.3 (132).0001\*≥12055.7 (112)33.7 (67)LDL *(mg/dL)*\<11056.7 (114)71.4 (142).002\*≥11043.3 (87)28.6 (57)TG *(mg/dL)*\<7536.3 (73)57.3 (114).0001\*≥7563.7 (128)42.7 (85)[^7]

3.4. The bivariate analysis in the high risk group {#sec3.4}
--------------------------------------------------

In a bivariate analysis of the high risk group, dyslipidemia in children was associated with a BMI ≥95th percentile and with parents having TC \> 240 mg/dL with a P value respectively of .006 and .0001 ([Table 7](#tbl7){ref-type="table"}).Table 7Bivariate analysis of the variables included in the study (according to the high risk group).Table 7Independents variablesDyslipidemia\
*Percentage (numbers)*No dyslipidemia\
*Percentage (numbers)P* valueGenreMale48.3 (100)54.9 (106).186Female51.7 (107)45.1 (87)Passive smokingYes17.9 (37)21.2 (41).395No82.1 (170)78.8 (152)BMI≥ 95th percentileYes15.5 (32)6.7 (13).006\*No84.5 (175)93.3 (180)Parents with TC \> 240 mg/dLYes27.1 (56)10.9 (21).0001\*No72.9(151)89.1 (172)First degree parents with premature coronary artery disease or equivalentYes2.4 (5)2.1 (4).817No97.6 (202)97.9 (189)Second degree parents with premature coronary artery disease or equivalentYe6.3 (13)4.1 (8).339No93.7 (194)95.9 (185)First or/and second degree parents with premature coronary artery disease or equivalentYes8.7 (18)5.7 (11).248Non91.3 (189)94.3 (182)Parents with diabetesYes5.8 (12)6.2 (12).86Non94.2 (195)93.8 (181)Parents with hypertensionYes3.9 (8)3.6 (7).9Non96.1 (199)96.4 (186)[^8]

Furthermore, according to the Pediatric Dyslipidemia Screening Guidelines from the 2011 Expert Panel, in the high risk group 62.3% of dyslipidemic children had at least 1 risk factor that qualified them for screening while 37.7% of them didn\'t have any risk factor and was significant with a *P* value of .0001. Also in the high risk group, children qualified for screening had higher frequency of dyslipidemia compared to those not qualified for screening and this is percentage of is a big percentage of missed children ([Table 8](#tbl8){ref-type="table"}).Table 8Bivariate analysis of children qualified for screening in the high risk group.Table 8Independents variablesDyslipidemia\
*Percentage (numbers)*No dyslipidemia\
*Percentage (numbers)P* valueChildren qualified for screeningYes62.3 (129)37.3 (72).0001\*No37.7 (78)62.7 (121)[^9]

Additionally, in the high risk group, high TG was independently associated with a BMI ≥ 95th percentile (*P* = .0001) ([Table 9](#tbl9){ref-type="table"}).Children with parents having TC \> 240 mg/dL was significantly correlated with high TC, high non-HDL-C and high LDL (*P *= .0001 for all variables) ([Table 10](#tbl10){ref-type="table"}).Table 9Bivariate analysis of BMI in the high risk group.Table 9Independents variablesBMI ≥95th percentile\
*Percentage (numbers)*BMI \< 95th percentile\
*Percentage (numbers)P* valueTotal cholesterol *(mg/dL)*\<17048.9 (22)53.5 (190).815170--19931.1 (14)27(96)≥20020 (9)19.4 (69)HDL *(mg/dL)*\<4026.7 (12)19.2 (68).21540--4522.2 (10)16.3 (58)≥4551.1 (23)64.5 (229)Non HDL *(mg/dL)*\<12044.4 (20)56.6 (201).27120--14428.9 (13)20.8 (74)≥14526.7 (12)22.5 (80)LDL *(mg/dL)*\<11071.1 (32)63.1 (224).183110--12920 (9)16.6 (59)≥1308.9 (4)20.3 (72)TG *(mg/dL)*\<7515.6 (7)50.7 (180.0001\*75--9924.4 (11)21.1 (75)≥10060(27)28.2(100)[^10]Table 10Bivariate analysis of parents high TC in the high risk group.Table 10Independents variablesParents with TC \> 240 mg/dL\
*Percentage numbers)*Parents with TC ≤ 240 mg/dL\
*Percentage (numbers)P*valueTotal cholesterol *(mg/dL)*\<17031.5 (25)57.9(187).0001\*170--19927.3 (21)27.6 (89)≥20040.3 (31)14.6 (47)HDL *(mg/dL)*\<4024.7 (19)18.9 (61).46940--4514.3 (11)17.6 (57)≥4561 (47)63.5 (205Non HDL *(mg/dL)*\<12031.2 (24)61 (197).0001\*120--14424.7 (19)21.1 (68)≥14544.2 (34)18 (58)LDL *(mg/dL)*\<11041.6 (32)69.3 (224).0001\*110--12916.9 (13)17 (55)≥13041.6 (32)13.6 (44)TG *(mg/dL)*\<7539 (30)48.6 (157).24575--9922.1 (17)21.4 (69)≥10039 (30)30 (97)[^11]

In the high risk group, children not qualified for screening had a significant correlation with an elevated TC, high non-HDL-C, high TG high LDL with a P value of .0001 for all variables ([Table 11](#tbl11){ref-type="table"}).Table 11Bivariate analysis of children qualified for screening in the high risk group.Table 11IndependentsvariablesQualified for screening\
*Percentage (numbers)*Not qualified for screening\
*Percentage (numbers)P* valueTotal cholesterol *(mg/dL)*\<17040.8 (82)65.3 (130).0001\*170--19930.8 (62)24.1 (48)≥20028.4 (57)10.6 (21)HDL *(mg/dL)*\<4023.9 (48)16.1 (32).0740--4518.4 (37)15.6 (31)≥4557.7 (116)68.3 (136)Non HDL *(mg/dL)*\<12044.3 (89)66.3 (132).0001\*120--14422.4 (45)21.1 (42)≥14533.3 (67)12.6 (25)LDL *(mg/dL)*\<11056.7 (114)71.4 (142).0001\*110--12916.4 (33)17.6 (35)≥13026.9 (54)11.1 (22)TG *(mg/dL)*\<7536.3 (73)57.3 (114).0001\*75--9923.4 (47)19.6 (39)≥10040.3 (81)23.1 (46)[^12]

4. Discussion {#sec4}
=============

According to a systemic review made by Don P. Wilson published on May 2015 on universal cholesterol screening during youth, supplementary approaches are needed to improve screening quality and especially because of the association between high lipid level and the prevalence of premature coronary artery disease \[[@bib20]\]. In this study the overall prevalence of borderline high dyslipidemia was 77.3% which is significantly higher compared to Mexican children (54.3%) \[[@bib21]\]. We reported in the high risk group in our study, 51.7% of dyslipidemic children and this percentage were significantly higher compared to the United State of America (USA) children (20% of children belong to high risk group in USA) \[[@bib1]\].

Furthermore the prevalence of particular lipid abnormality in the borderline high risk group in our study was, 47% for TC, 44.8% for non-HDL-C, 36% for LDL, 53.3% for TG and 37% for HDL. While the prevalence in Mexican children were reported as follow, 43.5% for TC, 44.1% for non-HDL-C, 29.9% for LDL, 63% for TG and 46.3% for HDL \[[@bib21]\]. In Lebanon we have higher TC, higher non HDL-C and higher LDL but lesser TG. Additionally the prevalence of particular lipid abnormality in the high risk group in our study was, 19.5% for TC, 23% for non-HDL-C, 19% for LDL, 31.8% for TG and 20% for HDL. While the prevalence in USA children were reported as follow, 8% for TC, 12% for non-HDL-C, 7% for LDL, 12% for TG and 15% for HDL \[[@bib1]\]. We can find that in Lebanon we have higher prevalence of all lipids, which might be due to genetic predisposition and to bad dietary.

In the borderline high risk group and the high risk group, BMI≥95th percentile and parents having TC \> 240 mg/dL were significantly associated to dyslipidemia with a *P* value respectively of .006 and .0001. BMI≥95th percentile was significantly correlated to abnormal level of TG in both groups with a P value of .0001 similar to the study made by Marie-Hélène Gannagé-Yared on 2016 that confirmed the association between obesity and high level of TG \[[@bib8]\]. Children with parents having TC \> 240 mg/dL was significantly correlated with high TC, high non-HDL-C and high LDL (*P* = .0001 for all variables) in both groups, this confirms the genetic predisposition to dyslipidemia in the Lebanese population.

In addition, according to the Pediatric Dyslipidemia Screening Guidelines from the 2011 Expert Panel, in the borderline high risk group and in the high risk group, respectively 42.4% and 37.7% of dyslipidemic children didn\'t have any risk factor that qualify them for screening. This means that we are missing above a third of our dyslipidemic Lebanese children ([Fig. 3](#fig3){ref-type="fig"}).Fig. 3Study flow diagram.Fig. 3

Finally because the highest frequency of dyslipidemic children was found at the age of 10 in the borderline high risk group and at the age of 6 in the high risk group, it is advised to repeat the screening of our previously screened non dyslipidemic children at 6 and at 10 years old.

4.1. Limitations of the study {#sec4.1}
-----------------------------

Our study was limited by the small sample size and also by the small age of children\'s parents so the manifestations of atherosclerosis did not became clinically evident and we considered them not having premature coronary artery disease or equivalent while they might have it in the future.

5. Conclusion {#sec5}
=============

Because of the high prevalence of dyslipidemia in Lebanese children according to this study compared to other studies, it is preferable to review the latest pediatric dyslipidemia screening guidelines by performing a universal screening program since above third of our dyslipidemic Lebanese children will be missed. Dyslipidemia in this study was significantly associated to BMI≥95th percentile so it is advised to consider a healthier diet modification to decrease the progression of cardiovascular disease and the emergence of premature coronary artery disease in our population. It is estimated that increasing the sample size could lead to more significant results so it might be essential to increase our sample size in order to get a better estimation on the population.
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[^1]: Qualitative variables are expressed as a percentage and quantitative variables in (brackets) as average ± Standard deviation.

[^2]: \* Indicates a significant difference between the two groups with a value of *P* \< 0.05.
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